Molecular mechanisms in the brain are assumed to cause the symptoms and severity of neuropsychiatric disorders. This review concerns the elusive nature of relationships between the severity of depressive disorders and neuromolecular processes studied by positron emission tomography (PET). Recent PET studies of human depression have focused on serotonergic, dopaminergic, muscarinic, nicotinic, and GABAergic receptors, as well as central processes dependent on monoamine oxidase, phosphodiesterase type 4, amyloid plaques, neurofibrillar tangles, and P-glycoprotein. We find that reliable causal links between neuromolecular mechanisms and relief from depressive disorders have yet to be convincingly demonstrated.This situation may contribute to the currently limited use of PET for exploring the neuropathways that are currently viewed as being responsible for beneficial effects of antidepressant treatment regimes. © 2013 Smith and Jakobsen.
CITATION STYLE
Smith, D. F., & Jakobsen, S. (2013). Molecular neurobiology of depression: PET findings on the elusive correlation with symptom severity. Frontiers in Psychiatry. https://doi.org/10.3389/fpsyt.2013.00008
Mendeley helps you to discover research relevant for your work.